BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 17973362)

  • 1. Structure-activity studies of novel cyanoguanidine ATP-sensitive potassium channel openers for the treatment of overactive bladder.
    Perez-Medrano A; Brune ME; Buckner SA; Coghlan MJ; Fey TA; Gopalakrishnan M; Gregg RJ; Kort ME; Scott VE; Sullivan JP; Whiteaker KL; Carroll WA
    J Med Chem; 2007 Nov; 50(24):6265-73. PubMed ID: 17973362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and synthesis of novel cyanoguanidine ATP-sensitive potassium channel openers for the treatment of overactive bladder.
    Perez-Medrano A; Buckner SA; Coghlan MJ; Gregg RJ; Gopalakrishnan M; Kort ME; Lynch JK; Scott VE; Sullivan JP; Whiteaker KL; Carroll WA
    Bioorg Med Chem Lett; 2004 Jan; 14(2):397-400. PubMed ID: 14698167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and structure-activity relationships of a novel series of 2,3,5,6,7,9-hexahydrothieno[3,2-b]quinolin-8(4H)-one 1,1-dioxide K(ATP) channel openers: discovery of (-)-(9S)-9-(3-bromo-4-fluorophenyl)-2,3,5,6,7,9- hexahydrothieno[3,2-b]quinolin-8(4H)-one 1,1-dioxide (A-278637), a potent K(ATP) opener that selectively inhibits spontaneous bladder contractions.
    Carroll WA; Altenbach RJ; Bai H; Brioni JD; Brune ME; Buckner SA; Cassidy C; Chen Y; Coghlan MJ; Daza AV; Drizin I; Fey TA; Fitzgerald M; Gopalakrishnan M; Gregg RJ; Henry RF; Holladay MW; King LL; Kort ME; Kym PR; Milicic I; Tang R; Turner SC; Whiteaker KL; Yi L; Zhang H; Sullivan JP
    J Med Chem; 2004 Jun; 47(12):3163-79. PubMed ID: 15163196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of substitution on 9-(3-bromo-4-fluorophenyl)-5,9-dihydro-3H,4H-2,6-dioxa-4- azacyclopenta[b]naphthalene-1,8-dione, a dihydropyridine ATP-sensitive potassium channel opener.
    Altenbach RJ; Brune ME; Buckner SA; Coghlan MJ; Daza AV; Fabiyi A; Gopalakrishnan M; Henry RF; Khilevich A; Kort ME; Milicic I; Scott VE; Smith JC; Whiteaker KL; Carroll WA
    J Med Chem; 2006 Nov; 49(23):6869-87. PubMed ID: 17154517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of a novel ATP-sensitive K+ channel opener, A-251179, on urinary bladder relaxation and cystometric parameters.
    Shieh CC; Brune ME; Buckner SA; Whiteaker KL; Molinari EJ; Milicic IA; Fabiyi AC; Daza A; Brioni JD; Carroll WA; Matsushita K; Yamada M; Kurachi Y; Gopalakrishnan M
    Br J Pharmacol; 2007 Jun; 151(4):467-75. PubMed ID: 17435796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological characterization of urinary bladder smooth muscle contractility following partial bladder outlet obstruction in pigs.
    Milicic I; Buckner SA; Daza A; Coghlan M; Fey TA; Brune ME; Gopalakrishnan M
    Eur J Pharmacol; 2006 Feb; 532(1-2):107-14. PubMed ID: 16487510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and SAR of novel potassium channel openers targeted for urge urinary incontinence. 1. N-Cyanoguanidine bioisosteres possessing in vivo bladder selectivity.
    Butera JA; Antane MM; Antane SA; Argentieri TM; Freeden C; Graceffa RF; Hirth BH; Jenkins D; Lennox JR; Matelan E; Norton NW; Quagliato D; Sheldon JH; Spinelli W; Warga D; Wojdan A; Woods M
    J Med Chem; 2000 Mar; 43(6):1187-202. PubMed ID: 10737752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and structure-activity relationships of a novel series of tricyclic dihydropyridine-based KATP openers that potently inhibit bladder contractions in vitro.
    Carroll WA; Agrios KA; Altenbach RJ; Buckner SA; Chen Y; Coghlan MJ; Daza AV; Drizin I; Gopalakrishnan M; Henry RF; Kort ME; Kym PR; Milicic I; Smith JC; Tang R; Turner SC; Whiteaker KL; Zhang H; Sullivan JP
    J Med Chem; 2004 Jun; 47(12):3180-92. PubMed ID: 15163197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional implication of spare ATP-sensitive K(+) channels in bladder smooth muscle cells.
    Shieh CC; Feng J; Buckner SA; Brioni JD; Coghlan MJ; Sullivan JP; Gopalakrishnan M
    J Pharmacol Exp Ther; 2001 Mar; 296(3):669-75. PubMed ID: 11181891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [125I]A-312110, a novel high-affinity 1,4-dihydropyridine ATP-sensitive K+ channel opener: characterization and pharmacology of binding.
    Davis-Taber R; Molinari EJ; Altenbach RJ; Whiteaker KL; Shieh CC; Rotert G; Buckner SA; Malysz J; Milicic I; McDermott JS; Gintant GA; Coghlan MJ; Carroll WA; Scott VE; Gopalakrishnan M
    Mol Pharmacol; 2003 Jul; 64(1):143-53. PubMed ID: 12815170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-aryl-3,3,3-trifluoro-2-hydroxy-2-methylpropanamides: KATP potassium channel openers. Modifications on the western region.
    Ohnmacht CJ; Russell K; Empfield JR; Frank CA; Gibson KH; Mayhugh DR; McLaren FM; Shapiro HS; Brown FJ; Trainor DA; Ceccarelli C; Lin MM; Masek BB; Forst JM; Harris RJ; Hulsizer JM; Lewis JJ; Silverman SM; Smith RW; Warwick PJ; Kau ST; Chun AL; Grant TL; Howe BB; Neilson KL
    J Med Chem; 1996 Nov; 39(23):4592-601. PubMed ID: 8917648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (-)-(9S)-9-(3-Bromo-4-fluorophenyl)-2,3,5,6,7,9-hexahydrothieno[3,2-b]quinolin-8(4H)-one 1,1-dioxide (A-278637): a novel ATP-sensitive potassium channel opener efficacious in suppressing urinary bladder contractions. II. in vivo characterization.
    Brune ME; Fey TA; Brioni JD; Sullivan JP; Williams M; Carroll WA; Coghlan MJ; Gopalakrishnan M
    J Pharmacol Exp Ther; 2002 Oct; 303(1):387-94. PubMed ID: 12235275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GW427353 (solabegron), a novel, selective beta3-adrenergic receptor agonist, evokes bladder relaxation and increases micturition reflex threshold in the dog.
    Hicks A; McCafferty GP; Riedel E; Aiyar N; Pullen M; Evans C; Luce TD; Coatney RW; Rivera GC; Westfall TD; Hieble JP
    J Pharmacol Exp Ther; 2007 Oct; 323(1):202-9. PubMed ID: 17626794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bladder-relaxant properties of the novel benzofuroindole analogue LDD175.
    dela Peña IC; Yoon SY; Kim SM; Lee GS; Ryu JH; Park CS; Kim YC; Cheong JH
    Pharmacology; 2009; 83(6):367-78. PubMed ID: 19451752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery and structure-activity relationships of a novel series of benzopyran-based K(ATP) openers for urge urinary incontinence.
    Zhang X; Qiu Y; Li X; Bhattacharjee S; Woods M; Kraft P; Lundeen SG; Sui Z
    Bioorg Med Chem; 2009 Jan; 17(2):855-66. PubMed ID: 19101153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and bladder smooth muscle relaxing properties of substituted 3-amino-4-aryl-(and aralkyl-)cyclobut-3-ene-1,2-diones.
    Butera JA; Jenkins DJ; Lennox JR; Sheldon JH; Norton NW; Warga D; Argentieri TM
    Bioorg Med Chem Lett; 2005 May; 15(10):2495-501. PubMed ID: 15863304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of highly potent and selective biphenylacylsulfonamide-based beta3-adrenergic receptor agonists and evaluation of physical properties as potential overactive bladder therapies: part 5.
    Hattori K; Toda S; Imanishi M; Itou S; Nakajima Y; Washizuka K; Araki T; Hamashima H; Tomishima Y; Sakurai M; Matsui S; Imamura E; Ueshima K; Yamamoto T; Yamamoto N; Ishikawa H; Nakano K; Unami N; Hamada K; Matsumura Y; Takamura F
    J Med Chem; 2009 May; 52(9):3063-72. PubMed ID: 19366244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and pharmacological evaluation of N,N'-diarylguanidines as potent sodium channel blockers and anticonvulsant agents.
    Reddy NL; Fan W; Magar SS; Perlman ME; Yost E; Zhang L; Berlove D; Fischer JB; Burke-Howie K; Wolcott T; Durant GJ
    J Med Chem; 1998 Aug; 41(17):3298-302. PubMed ID: 9703475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo characterization of a novel naphthylamide ATP-sensitive K+ channel opener, A-151892.
    Gopalakrishnan M; Buckner SA; Shieh CC; Fey T; Fabiyi A; Whiteaker KL; Davis-Taber R; Milicic I; Daza AV; Scott VE; Castle NA; Printzenhoff D; London B; Turner SC; Carroll WA; Sullivan JP; Coghlan MJ; Brune ME
    Br J Pharmacol; 2004 Sep; 143(1):81-90. PubMed ID: 15302680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, and biological activity of 4-[(4-cyano-2-arylbenzyloxy)-(3-methyl-3H-imidazol-4-yl)methyl]benzonitriles as potent and selective farnesyltransferase inhibitors.
    Wang L; Wang GT; Wang X; Tong Y; Sullivan G; Park D; Leonard NM; Li Q; Cohen J; Gu WZ; Zhang H; Bauch JL; Jakob CG; Hutchins CW; Stoll VS; Marsh K; Rosenberg SH; Sham HL; Lin NH
    J Med Chem; 2004 Jan; 47(3):612-26. PubMed ID: 14736242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.